TMCnet News

Research and Markets: North America Genetic Testing Market - Industry Analysis and Market Forecast (2014-2020)
[September 16, 2014]

Research and Markets: North America Genetic Testing Market - Industry Analysis and Market Forecast (2014-2020)


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/364c23/north_america) has announced the addition of the "North America Genetic Testing Market - Industry Analysis and Market Forecast (2014-2020)" report to their offering.

The genetic testing market in North America is the largest in the world and is estimated at US$8.6 billion in 2014, and is further anticipated to post a strong CAGR of 18% in 2014-2020

Genetic testing offers the prospects for fastest growth among all other segments within the molecular diagnostics market. Primary growth drivers for genetic testing include high incidence of genetic diseases, aging population ad greater awareness.



Personalized medicine is one area that is likely to benefit greatly from technological developments in genetic testing, which is of assistance not only in better diagnosis of genetic diseases but also in deciding on the most ideal medical regimen based on an individual's DNA structure for ensuring that the drug responds in a superior manner.

In the realm of personalized medicine Direct-to-consumer (DTC) genetic testing has emerged as a major trend in the market and is expected to make a positive impact on the overall growth of the genetic testing market. In North America, the United States is set to have the highest demand for genetic testing and this demand is estimated to outpace the cumulative North American CAGR in the time frame 2014 to 2020. Newborn screening leads the region's genetic testing market.


Key Topics Covered:

1. Introduction

2. North America Genetic Testing - Market Forces

3. North America Genetic Testing Market, By Types

4. North America Genetic Testing Market, By Geography

5. Competitive Landscape

6. Company Profiles

  • 23Andme, Inc
  • Abbott Molecular
  • Ariosa Diagnostics, Inc
  • Biohelix Corporation (Wholly Owned Subsidiary Of Quidel)
  • Biomerieux S.A
  • Celera Corporation
  • Cepheid
  • Genentech, Inc

For more information visit http://www.researchandmarkets.com/research/364c23/north_america


[ Back To TMCnet.com's Homepage ]